Kyoto Researchers Find Key to Treat Resistant Cancer

Scientists at Kyoto University discovered why 85% of colorectal cancer patients don't respond to common immunotherapy drugs like Opdivo. They identified a protein that blocks the treatment, opening the door to new combination therapies that could help thousands.